# Melatonin and Response to Lithium

> **NCT05878730** · — · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 60 (estimated)

## Conditions studied

- Bipolar Disorder I

## Interventions

- **DIAGNOSTIC_TEST:** urine collection
- **DIAGNOSTIC_TEST:** Level of Proteins
- **DIAGNOSTIC_TEST:** Level of mRNA and miRNA
- **DIAGNOSTIC_TEST:** Level of plasmatic and intraerythrocytic lithium

## Key facts

- **NCT ID:** NCT05878730
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-26
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05878730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05878730, "Melatonin and Response to Lithium". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05878730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*